Global Coronary Stents Market 2014-2018: Key Vendors are

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Global Coronary Stents Market 2014-2018: Key Vendors are Abbott, Boston Scientific, Medtronic and Terumo

Dublin, July 16, 2014 (GLOBE NEWSWIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/65...l_coronary ) has announced the addition of the "Global Coronary Stents Market 2014-2018" report to their offering.

A coronary stent is a tiny mesh-like tube made up of thin wires of stainless steel, cobalt-based alloy with mechanism of self-expansion. Coronary stents are used to prevent artery blockages that may occur in patients after they undergo angioplasty. It acts as a support or scaffold, in keeping the vessel open, it helps to improve blood flow to the heart muscle and reduces the pain of angina.

Stents are used to treat people who suffer from CVD, CHD and PVD, which occur as a result of hypertension, ageing, smoking, a sedentary lifestyle, a high cholesterol diet, and genes. Coronary stents such as Drug Eluting stents, Bare Metal stents and Bioabsorbable stents help in the risk of restenosis, which prevents narrowing or clogging. Thus, using coronary stents eliminates the need for repeated revascularization procedures and helps reduce arterial blockage and ensures smooth blood flow through the arteries.

The analysts forecast the Global Coronary Stents market will grow at a CAGR of 4.54 percent over the period 2013-2018.

This report covers the present scenario and the growth prospects of the Global Coronary Stents market for the period 2014-2018. This report considers 2013 as the base year and provides data for the trailing 12 months. It also presents the vendor landscape and a corresponding detailed analysis of the top four vendors in the market. To calculate the market size, the report considers revenue generated from the below-mentioned segments:

  • Drug Eluting Stents
  • Bare Metal Stents

In addition, the report discusses the major drivers that influence the growth of the Global Coronary Stents market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

The report, the Global Coronary Stents Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Coronary Stents market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.


Key Topics Covered:

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

04. Market Research Methodology

05. Introduction

06. Market Landscape

07. Market Segmentation by Product

08. Geographical Segmentation

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

17. Key Vendor Analysis

18. Other Reports in this Series


Companies Mentioned:

  • Abbott Laboratories
  • Boston Scientific Corp.
  • Medtronic Inc.
  • Terumo Corp.
  • B. Braun Melsungen AG
  • Biosensors International Ltd
  • BIOTRONIK SE & Co. KG
  • Cook Medical Inc.
  • Johnson & Johnson
  • Lepu Medical Technology Co. Ltd.
  • MicroPort Scientific Corp
  • Sorin Group USA Inc.


For more information visit http://www.researchandmarkets.com/research/65...al_coronar

Research and Markets Laura Wood, Senior Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Stents

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 146

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 72

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 626

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 168

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 189

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 334

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 42

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 92

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 356

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 570

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading

Top 5 Most Recently Viewed Articles

Kal Raman Joins Photon to Drive Strategic AI Innovation Forward

Updated Category News Views 357

Kal Raman Joins Photon as Strategic Advisor to CEO Photon, a leader in digital and AI solutions, is excited to announce that Kal Raman has been appointed as a Strategic Advisor to the CEO. His primary focus will be to work closely with the executive leadership team to build strong relationships with major cloud and technology platforms in the AI ecosystem. This strategic...

Continue Reading
Fiverr's Q3 2024: Growth Strategies and Financial Insights

Updated Category News Views 319

Fiverr Reports Strong Q3 2024 Results Fiverr International Ltd. (NYSE: FVRR) has delivered impressive financial results for the third quarter of 2024. This success demonstrates the company's commitment to enhancing its services and reaching growth targets even amidst a challenging economic environment. Fiverr's strategy focuses on increasing its take rate by offering...

Continue Reading
Upcoming Legal Action for Jasper Therapeutics Investors Explained

Updated Category News Views 234

Legal Investigation Updates for Jasper Investors As the legal landscape around Jasper Therapeutics, Inc. (NASDAQ: JSPR) evolves, important updates are emerging for investors affected by recent developments. Faruqi & Faruqi, LLP, a prominent national securities law firm, is currently investigating claims on behalf of shareholders who may have suffered losses due to the...

Continue Reading
Naf Naf Grill Unveils Flavor-Packed Spiced Meatballs Today

Updated Category News Views 91

Introducing Spiced Meatballs at Naf Naf Grill Naf Naf Grill has just launched an exciting new dish: Spiced Meatballs. These flavorful meatballs are crafted with care to showcase the vibrant essence of Middle Eastern cuisine, making them a perfect addition to enhance your dining experience this fall. Rich Middle Eastern Flavors Made from 100% beef, these Spiced Meatballs...

Continue Reading
Pulmatrix Shares Q1 2025 Financial Results and New Directions

Updated Category News Views 170

Overview of Pulmatrix's Recent Developments Pulmatrix, Inc. is a biopharmaceutical entity focused on developing innovative inhaled therapeutic products to treat migraine and respiratory diseases, utilizing its specialized iSPERSE™ technology. In a recent announcement, the company outlined its financial performance for the first quarter of 2025. Key Financial Outcomes...

Continue Reading